Spironolactone Does Not Cause UTIs
No, spironolactone does not cause urinary tract infections in women using it for anti-androgen therapy. The documented side effects of spironolactone are well-established through multiple guidelines and extensive clinical experience, and UTI is not among them.
Evidence from Guidelines and Clinical Data
The most comprehensive guideline evidence from the Journal of the American Academy of Dermatology (2019) and the American Academy of Dermatology Guidelines (2016) extensively detail spironolactone's adverse effect profile in women treated for acne and other androgen-mediated conditions 1, 2. The documented side effects include:
- Menstrual irregularities (15-30%) - the most common side effect, dose-dependent
- Breast tenderness (3-5%)
- Dizziness (3-4%)
- Nausea (2-4%)
- Headache (2%)
- Polyuria (1-2%) - increased urination frequency
- Fatigue (1-2%)
Why Polyuria Is Not a UTI Risk Factor
While spironolactone causes polyuria (increased urination) in 1-2% of patients due to its diuretic mechanism 1, 2, this does not translate to increased UTI risk. Polyuria is simply more frequent urination from the medication's intended diuretic effect, not a pathological condition that predisposes to infection.
Extensive Safety Data Shows No UTI Association
Multiple large retrospective studies involving hundreds of patients and over 30 million person-years of follow-up have been conducted on spironolactone safety 1. None of these studies identified UTI as a complication. A specific study of 967 women aged 18-45 taking spironolactone 50-200 mg daily for acne found no association with UTIs 2.
Clinical Monitoring Recommendations
The established monitoring for spironolactone focuses on:
- Potassium levels - only in patients with risk factors (renal disease, cardiovascular disease, concurrent ACE inhibitors/ARBs), not required in healthy young women 1, 2
- Pregnancy prevention - due to potential feminization of male fetuses 3
- Menstrual irregularities - can be managed with concurrent oral contraceptives 1, 2
No guideline recommends monitoring for or counseling about UTI risk because it is not an established adverse effect.
Important Caveat
If a woman on spironolactone develops UTI symptoms, this should be evaluated and treated according to standard UTI guidelines 4, 5, but the spironolactone itself is not the causative factor. The UTI would be coincidental, not medication-related.